{"organizations": [], "uuid": "7fe1f23a71f559b8a011ce2d238e93e3c477f816", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180116.html", "section_title": "Archive News &amp; Video for Tuesday, 16 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-bayer-fda-report-reaffirms-safety/brief-bayer-fda-report-reaffirms-safety-profile-and-effectiveness-of-xarelto-in-routine-clinical-practice-idUSFWN1PB13T", "country": "US", "domain_rank": 408, "title": "BRIEF-Bayer: FDA Report Reaffirms Safety Profile And Effectiveness Of Xarelto In Routine Clinical Practice", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.998, "site_type": "news", "published": "2018-01-16T21:34:00.000+02:00", "replies_count": 0, "uuid": "7fe1f23a71f559b8a011ce2d238e93e3c477f816"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-bayer-fda-report-reaffirms-safety/brief-bayer-fda-report-reaffirms-safety-profile-and-effectiveness-of-xarelto-in-routine-clinical-practice-idUSFWN1PB13T", "ord_in_thread": 0, "title": "BRIEF-Bayer: FDA Report Reaffirms Safety Profile And Effectiveness Of Xarelto In Routine Clinical Practice", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "bayer ag", "sentiment": "negative"}, {"name": "bayer", "sentiment": "negative"}, {"name": "lto", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 16 (Reuters) - BAYER AG:\n* FDA REPORT REAFFIRMS SAFETY PROFILE AND EFFECTIVENESS OF BAYER'S XARELTO IN ROUTINE CLINICAL PRACTICE Source text: bit.ly/2DDuMIB Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://bit.ly/2DDuMIB", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-16T21:34:00.000+02:00", "crawled": "2018-01-17T20:14:39.021+02:00", "highlightTitle": ""}